MYD88 and hepatocellular carcinoma: Meanwhile, in the exploratory in vitro data, LPS further restored the downstream targets of TLR4/MyD88, including Sp1, STAT3, p38 MAPK and NF‐κB p65, in geniposide‐treated HCC cells (Figure 5e).